Calanolide A - Revision history

Prab: CSV import

2025-03-23T18:56:00Z

CSV import

← Older revision		Revision as of 18:56, 23 March 2025
Line 1:		Line 1:
	{{Short description\|~~An article about Calanolide A, an anti-HIV~~ compound}}		{{Short description\|Chemical compound with potential medicinal properties}}

	~~==Calanolide A==~~		[[File:Calanolide_A.svg\|thumb\|right\|Chemical structure of Calanolide A]]
	[[File:~~Craun_Research_Sdn_Bhd_signage~~.~~jpg~~\|thumb\|right\|~~Craun Research Sdn Bhd, involved in the research~~ of Calanolide A]]
	'''Calanolide A''' is a naturally occurring [[~~chemical compound~~]] that has garnered interest for its potential ~~use as an~~ [[~~antiretroviral drug~~]] in the ~~treatment of~~ [[HIV~~/AIDS~~]]. It is ~~a member of~~ the ~~class of compounds known as~~ [[~~coumarins~~]], which ~~are known for their diverse biological activities~~.		'''Calanolide A''' is a naturally occurring [[coumarin]] derivative that has garnered interest for its potential [[antiviral]] properties, particularly against the [[Human Immunodeficiency Virus (HIV)]]. It is isolated from the tropical tree ''[[Calophyllum lanigerum]]'', which is native to [[Malaysia]].

	==Discovery and ~~Source~~==		==Discovery and Isolation==
	Calanolide A was first isolated from the ~~tropical tree~~ ''[[Calophyllum lanigerum]]''~~, which is native to~~ the [[~~rainforests~~]] of ~~[[Malaysia]]~~. The compound was ~~discovered~~ during a screening program aimed at ~~identifying~~ new agents with activity against ~~the [[human immunodeficiency virus]] (~~HIV).		Calanolide A was first isolated in the early 1990s from the latex of ''Calophyllum lanigerum'' trees found in the Malaysian rainforest. The discovery was part of a collaborative effort between the [[National Cancer Institute]] (NCI) and the Malaysian government to explore the medicinal potential of native plants. The compound was identified during a screening program aimed at finding new agents with activity against HIV.

	==Chemical Structure==		==Chemical Structure==
	Calanolide A is a complex molecule ~~with a~~ unique ~~structure that includes a coumarin core. Its chemical formula is C<sub>20</sub>H<sub>18</sub>O<sub>5</sub>. The presence of multiple~~ [[~~hydroxyl groups~~]] ~~and~~ a [[~~lactone~~]] ring is ~~characteristic~~ of ~~its structure~~, ~~contributing~~ to its ~~biological activity~~.		[[File:Calanolide_A.svg\|thumb\|left\|Calanolide A structure]]
			Calanolide A is a complex molecule characterized by its unique [[coumarin]] backbone. The chemical structure includes a [[chromene]] ring system, which is essential for its biological activity. The presence of various functional groups, such as hydroxyl and methoxy groups, contributes to its interaction with viral enzymes.

	==Mechanism of Action==		==Mechanism of Action==
	Calanolide A ~~acts as a [[non-nucleoside reverse transcriptase inhibitor]] (NNRTI). It binds to a specific site on~~ the [[reverse transcriptase]] enzyme of HIV, ~~inhibiting its activity and preventing~~ the virus ~~from replicating its [[genetic material]]. This mechanism is similar to other NNRTIs used in [[antiretroviral therapy]]~~.		Calanolide A exhibits its antiviral effects primarily by inhibiting the [[reverse transcriptase]] enzyme of HIV. This enzyme is crucial for the replication of the virus, as it converts viral RNA into DNA, allowing integration into the host genome. By blocking this process, Calanolide A prevents the proliferation of the virus within the host cells.

	==Research and Development==		==Research and Development==
	Research into Calanolide A has been ~~conducted~~ by ~~various institutions~~, including [[Craun Research Sdn Bhd]], ~~which has been~~ involved in the development ~~and potential commercialization~~ of ~~this compound. Studies have shown that Calanolide A exhibits potent activity against HIV-1, the most common strain of the virus~~.		Research into Calanolide A has been spearheaded by several organizations, including [[Craun Research Sdn Bhd]], a Malaysian company involved in the development of natural products for pharmaceutical use.

	~~==Potential Benefits and Challenges==~~		[[File:Craun_Research_Sdn_Bhd_signage.jpg\|thumb\|right\|Craun Research Sdn Bhd, involved in the research of Calanolide A]]
	~~The potential benefits of Calanolide A include its novel mechanism of action and its effectiveness against drug-resistant strains of HIV~~. ~~However~~, ~~challenges remain~~ in ~~its development, including~~ the ~~need for further clinical trials to establish its safety and efficacy in humans.~~

	==Related ~~pages~~==		Clinical trials have been conducted to evaluate the safety and efficacy of Calanolide A in humans. Initial studies have shown promise, but further research is needed to fully understand its potential as a therapeutic agent.

			==Potential Applications==
			Beyond its antiviral properties, Calanolide A is being investigated for other medicinal uses. Its unique structure and mechanism of action make it a candidate for the development of new drugs targeting various viral infections. Additionally, its natural origin and relatively low toxicity profile are advantageous for drug development.

			==Challenges and Future Directions==
			The development of Calanolide A as a therapeutic agent faces several challenges, including the sustainable sourcing of the raw material and the optimization of its pharmacokinetic properties. Future research aims to address these issues and explore synthetic analogs that may offer improved efficacy and stability.

			==Related Pages==
			* [[Coumarin]]
			* [[Reverse transcriptase inhibitor]]
	* [[HIV/AIDS]]		* [[HIV/AIDS]]
	* [[~~Antiretroviral drug~~]]		* [[Natural product]]
	* [[Non-nucleoside reverse transcriptase inhibitor]]
	* [[Coumarin]]		{{Portal\|Medicine\|Pharmacology}}

	[[Category:~~Antiretroviral~~ drugs]]		[[Category:Antiviral drugs]]
	[[Category:Coumarins]]		[[Category:Coumarins]]
	[[Category:HIV/AIDS research]]		[[Category:HIV/AIDS research]]
	~~<gallery>~~		[[Category:Natural products]]
	~~File~~:~~Calanolide_A.svg\|Calanolide A structure~~
	~~File:Craun_Research_Sdn_Bhd_signage.jpg\|Craun Research Sdn Bhd signage~~
	~~</gallery>~~
	~~== Calanolide A ==~~
	~~<gallery>~~
	~~File:Calanolide_A.svg\|Chemical structure of Calanolide A~~
	~~File:Craun_Research_Sdn_Bhd_signage.jpg\|Signage of Craun Research Sdn Bhd~~
	~~</gallery>~~

Prab: CSV import

2025-02-18T00:47:12Z

CSV import

← Older revision		Revision as of 00:47, 18 February 2025
Line 32:		Line 32:
	File:Calanolide_A.svg\|Calanolide A structure		File:Calanolide_A.svg\|Calanolide A structure
	File:Craun_Research_Sdn_Bhd_signage.jpg\|Craun Research Sdn Bhd signage		File:Craun_Research_Sdn_Bhd_signage.jpg\|Craun Research Sdn Bhd signage
			</gallery>
			== Calanolide A ==
			<gallery>
			File:Calanolide_A.svg\|Chemical structure of Calanolide A
			File:Craun_Research_Sdn_Bhd_signage.jpg\|Signage of Craun Research Sdn Bhd
	</gallery>		</gallery>

Prab: CSV import

2025-02-17T01:53:00Z

CSV import

← Older revision		Revision as of 01:53, 17 February 2025
Line 29:		Line 29:
	[[Category:Coumarins]]		[[Category:Coumarins]]
	[[Category:HIV/AIDS research]]		[[Category:HIV/AIDS research]]
			<gallery>
			File:Calanolide_A.svg\|Calanolide A structure
			File:Craun_Research_Sdn_Bhd_signage.jpg\|Craun Research Sdn Bhd signage
			</gallery>

Prab: CSV import

2025-02-16T05:41:53Z

CSV import

← Older revision		Revision as of 05:41, 16 February 2025
Line 1:		Line 1:
	~~'''~~Calanolide A''' is a naturally occurring [[non-nucleoside reverse transcriptase inhibitor]] (NNRTI) derived from the [[Calophyllum]] tree species. It was first discovered in the 1990s during a large-scale screening of plant extracts for anti-HIV ~~activity. Calanolide A has been the subject of extensive research due to its potential use in the treatment of [[HIV/AIDS]].~~		{{Short description\|An article about Calanolide A, an anti-HIV compound}}

	== ~~History~~ ==		==Calanolide A==
			[[File:Craun_Research_Sdn_Bhd_signage.jpg\|thumb\|right\|Craun Research Sdn Bhd, involved in the research of Calanolide A]]
			'''Calanolide A''' is a naturally occurring [[chemical compound]] that has garnered interest for its potential use as an [[antiretroviral drug]] in the treatment of [[HIV/AIDS]]. It is a member of the class of compounds known as [[coumarins]], which are known for their diverse biological activities.

	Calanolide A was first isolated from the [[Calophyllum lanigerum]] ~~tree in Sarawak~~, Malaysia~~, as part of a United States National Cancer Institute (NCI) program that aimed to identify potential anti-HIV compounds from natural sources~~. The compound was ~~found to have significant anti-~~HIV ~~activity, leading to further research and development~~.		==Discovery and Source==
			Calanolide A was first isolated from the tropical tree ''[[Calophyllum lanigerum]]'', which is native to the [[rainforests]] of [[Malaysia]]. The compound was discovered during a screening program aimed at identifying new agents with activity against the [[human immunodeficiency virus]] (HIV).

	== Structure ~~and Properties~~ ==		==Chemical Structure==
			Calanolide A is a complex molecule with a unique structure that includes a coumarin core. Its chemical formula is C<sub>20</sub>H<sub>18</sub>O<sub>5</sub>. The presence of multiple [[hydroxyl groups]] and a [[lactone]] ring is characteristic of its structure, contributing to its biological activity.

	Calanolide A is a [[~~dipyranocoumarin]], a type of [[coumarin~~]] ~~derivative~~. It ~~has a complex structure that includes~~ a [[~~lactone~~]] ~~ring~~ and a [[~~pyran~~]] ~~ring~~. ~~The compound~~ is ~~chiral, meaning it has a non-superimposable mirror image. The stereochemistry of Calanolide A is important for its anti-HIV activity~~.		==Mechanism of Action==
			Calanolide A acts as a [[non-nucleoside reverse transcriptase inhibitor]] (NNRTI). It binds to a specific site on the [[reverse transcriptase]] enzyme of HIV, inhibiting its activity and preventing the virus from replicating its [[genetic material]]. This mechanism is similar to other NNRTIs used in [[antiretroviral therapy]].

	== ~~Mechanism of Action~~ ==		==Research and Development==
			Research into Calanolide A has been conducted by various institutions, including [[Craun Research Sdn Bhd]], which has been involved in the development and potential commercialization of this compound. Studies have shown that Calanolide A exhibits potent activity against HIV-1, the most common strain of the virus.

	Calanolide A ~~acts as a non~~-~~nucleoside reverse transcriptase inhibitor (NNRTI)~~. ~~[[Reverse transcriptase]] is an enzyme that HIV uses to replicate~~ its ~~genetic material. By inhibiting this enzyme~~, ~~Calanolide A prevents~~ the ~~virus from replicating~~ and ~~spreading to new cells~~.		==Potential Benefits and Challenges==
			The potential benefits of Calanolide A include its novel mechanism of action and its effectiveness against drug-resistant strains of HIV. However, challenges remain in its development, including the need for further clinical trials to establish its safety and efficacy in humans.

	== ~~Clinical Development~~ ==		==Related pages==
			* [[HIV/AIDS]]
			* [[Antiretroviral drug]]
			* [[Non-nucleoside reverse transcriptase inhibitor]]
			* [[Coumarin]]

	The clinical development of Calanolide A has involved preclinical studies, phase I clinical trials, and phase II clinical trials. These studies have shown that Calanolide A has a good safety profile and is effective in reducing HIV viral load in patients. However, the development of drug resistance is a potential concern.		[[Category:Antiretroviral drugs]]
			[[Category:Coumarins]]
	~~== Future Prospects ==~~		[[Category:HIV/AIDS research]]

	While Calanolide A has shown promise as an anti-HIV drug, further research is needed to fully understand its potential benefits and risks. The development of new formulations and combination therapies may help to overcome some of the challenges associated with this compound.

	[[Category:~~Pharmacology~~]]
	[[Category:~~Antiviral drugs~~]]
	[[Category:HIV/AIDS]]
	~~{{Pharma-stub}}~~
	~~{{HIV-stub}}~~

Prab: CSV import

2024-02-28T21:07:50Z

CSV import

New page

'''Calanolide A''' is a naturally occurring [[non-nucleoside reverse transcriptase inhibitor]] (NNRTI) derived from the [[Calophyllum]] tree species. It was first discovered in the 1990s during a large-scale screening of plant extracts for anti-HIV activity. Calanolide A has been the subject of extensive research due to its potential use in the treatment of [[HIV/AIDS]].

== History ==

Calanolide A was first isolated from the [[Calophyllum lanigerum]] tree in Sarawak, Malaysia, as part of a United States National Cancer Institute (NCI) program that aimed to identify potential anti-HIV compounds from natural sources. The compound was found to have significant anti-HIV activity, leading to further research and development.

== Structure and Properties ==

Calanolide A is a [[dipyranocoumarin]], a type of [[coumarin]] derivative. It has a complex structure that includes a [[lactone]] ring and a [[pyran]] ring. The compound is chiral, meaning it has a non-superimposable mirror image. The stereochemistry of Calanolide A is important for its anti-HIV activity.

== Mechanism of Action ==

Calanolide A acts as a non-nucleoside reverse transcriptase inhibitor (NNRTI). [[Reverse transcriptase]] is an enzyme that HIV uses to replicate its genetic material. By inhibiting this enzyme, Calanolide A prevents the virus from replicating and spreading to new cells.

== Clinical Development ==

The clinical development of Calanolide A has involved preclinical studies, phase I clinical trials, and phase II clinical trials. These studies have shown that Calanolide A has a good safety profile and is effective in reducing HIV viral load in patients. However, the development of drug resistance is a potential concern.

== Future Prospects ==

While Calanolide A has shown promise as an anti-HIV drug, further research is needed to fully understand its potential benefits and risks. The development of new formulations and combination therapies may help to overcome some of the challenges associated with this compound.

[[Category:Pharmacology]]
[[Category:Antiviral drugs]]
[[Category:HIV/AIDS]]
{{Pharma-stub}}
{{HIV-stub}}